share_log

Recursion Pharmaceuticals | 144/A: Others

SEC announcement ·  Jun 15 05:16
Summary by Futu AI
Recursion Pharmaceuticals, Inc. officer Secora Michael is set to sell 15,000 Class A shares on 06/14/2024, as per the latest filing. The shares, valued at an aggregate market value of $139,081.62, were originally acquired on 06/13/2023 through a stock option exercise from the issuer, with payment made in cash on the same date. This planned transaction follows a series of sales over the past three months, where a total of 63,124 shares were sold for gross proceeds of $506,805.72.
Recursion Pharmaceuticals, Inc. officer Secora Michael is set to sell 15,000 Class A shares on 06/14/2024, as per the latest filing. The shares, valued at an aggregate market value of $139,081.62, were originally acquired on 06/13/2023 through a stock option exercise from the issuer, with payment made in cash on the same date. This planned transaction follows a series of sales over the past three months, where a total of 63,124 shares were sold for gross proceeds of $506,805.72.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.